Adagio Medical Holdings, Inc. (ADGM)
| Previous Close | 2.6200 |
| Open | 2.7000 |
| Bid | 5.2600 x 100 |
| Ask | 3.4100 x 100 |
| Day's Range | 2.7000 - 2.9500 |
| 52 Week Range | 2.4000 - 9.3400 |
| Volume | |
| Avg. Volume | 33,073 |
| Market Cap | 38.824M |
| Beta (5Y Monthly) | -0.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.7600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
LAGUNA HILLS, Calif., October 24, 2024--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; "Adagio Medical", "Adagio" or the "Company"), a leading innovator in catheter ablation technologies, today announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System. Procedures were performed by Professor William G. Stevenson, MD, at Vanderbilt University Medical Center in Nashville, TN and Dr. J. David Burkhardt at
- Business Wire
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
LAGUNA HILLS, Calif., October 07, 2024--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the "Company"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and participation in the 19th Annual International Symposium on Ventricular Arrhythmias, to be held at the New York Marriott at the Brooklyn Bridge on October 11-12, 2024.
